65 related articles for article (PubMed ID: 6281861)
1. [Effects of alpha-ketoglutarate of imidazole on fentanyl-induced bradycardia-bradydypnoea syndrome. Experimental study (author's transl)].
Valle Sanchiz J; Menénder González JJ; Ascorve Domínguez A
Rev Esp Anestesiol Reanim; 1982 Jan; 29(1):3-7. PubMed ID: 6281861
[No Abstract] [Full Text] [Related]
2. [The combination of etomidate and fentanyl as a short acting and introduction anaesthesia in the dog in experimental medicine (author's transl)].
Erhardt W; Neumann G; Pfeiffer U; Birk M; Blümel G
Anaesthesist; 1978 May; 27(5):228-33. PubMed ID: 665971
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.
Sawanishi H; Suzuki H; Yamamoto S; Waki Y; Kasugai S; Ohya K; Suzuki N; Miyamoto K; Takagi K
J Med Chem; 1997 Sep; 40(20):3248-53. PubMed ID: 9379444
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide-induced acute renal failure in conscious rats: effects of specific phosphodiesterase type 3 and 4 inhibition.
Jonassen TE; Graebe M; Promeneur D; Nielsen S; Christensen S; Olsen NV
J Pharmacol Exp Ther; 2002 Oct; 303(1):364-74. PubMed ID: 12235272
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
[TBL] [Abstract][Full Text] [Related]
6. Enhanced excitability of the uterus of the pregnant rabbit by imidazole stimulation of cyclic AMP phosphodiesterase.
Currie WB
J Reprod Fertil; 1980 Nov; 60(2):369-75. PubMed ID: 6253637
[TBL] [Abstract][Full Text] [Related]
7. A reversed-phase HPLC-based method for the assay of cyclic nucleotide phosphodiesterase activity.
Abbott BM; Thompson PE
Anal Biochem; 2005 Apr; 339(1):185-7. PubMed ID: 15766728
[No Abstract] [Full Text] [Related]
8. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
9. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
Birk S; Edvinsson L; Olesen J; Kruuse C
Eur J Pharmacol; 2004 Apr; 489(1-2):93-100. PubMed ID: 15063160
[TBL] [Abstract][Full Text] [Related]
10. [Blood gases analyses during short anaesthesia with fentanyl and etomidate (author's transl)].
Schockenhoff B; Hoffmann P; Plantiko P
Anaesthesist; 1980 Jun; 29(6):311-6. PubMed ID: 6773434
[TBL] [Abstract][Full Text] [Related]
11. New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors.
Devillers I; Pevet I; Jacobelli H; Durand C; Fasquelle V; Puaud J; Gaudillière B; Idrissi M; Moreau F; Wrigglesworth R
Bioorg Med Chem Lett; 2004 Jun; 14(12):3303-6. PubMed ID: 15149695
[No Abstract] [Full Text] [Related]
12. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect?
Townley RG
J Lab Clin Med; 1993 Jan; 121(1):15-7. PubMed ID: 8381147
[No Abstract] [Full Text] [Related]
13. Effect of isoproterenol on coronary blood flow and signal transduction responses in thyroxine-treated rabbit hearts.
Rodriguez E; Weiss HR; Gonzalez M; Tse J
J Mol Cell Cardiol; 1993 Aug; 25(8):939-47. PubMed ID: 8263963
[TBL] [Abstract][Full Text] [Related]
14. Characterization of phosphodiesterase 4 in guinea-pig macrophages: multiple activities, association states and sensitivity to selective inhibitors.
Kelly JJ; Barnes PJ; Giembycz MA
Br J Pharmacol; 1998 May; 124(1):129-40. PubMed ID: 9630352
[TBL] [Abstract][Full Text] [Related]
15. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
[TBL] [Abstract][Full Text] [Related]
16. [Modulator effect of N6-monobutyryl-cAMP in experimental inflammation of rat conjunctiva].
Giao NB; Cehovic G
J Pharmacol; 1982; 13(3):399-411. PubMed ID: 6290794
[No Abstract] [Full Text] [Related]
17. Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery.
Ohashi M; Dohi Y; Itoh T
Br J Pharmacol; 2000 Mar; 129(5):1000-6. PubMed ID: 10696101
[TBL] [Abstract][Full Text] [Related]
18. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Freye E; Neruda B; Smith OW
Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059.
Yamamoto S; Sugahara S; Ikeda K; Shimizu Y
Eur J Pharmacol; 2007 Mar; 559(2-3):219-26. PubMed ID: 17250824
[TBL] [Abstract][Full Text] [Related]
20. Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.
Kempson J; Pitts WJ; Barbosa J; Guo J; Omotoso O; Watson A; Stebbins K; Starling GC; Dodd JH; Barrish JC; Felix R; Fischer K
Bioorg Med Chem Lett; 2005 Apr; 15(7):1829-33. PubMed ID: 15780616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
